Who owns IOVANCE BIOTHERAPEUTICS, INC. (IOVA)? Elite investor 13F holders

4 tracked elite investors reported holding IOVANCE BIOTHERAPEUTICS, INC as of 2026-09-30, including D.E. Shaw, Bridgewater Associates, Renaissance Technologies LLC, Gotham Asset Management. Who bought, trimmed or exited each quarter, with links to the original SEC 13F filings.

4 tracked investors currently reported holding · Latest report period: 2026-09-30

Reported holders and securities, including exits (up to 20)

Reported holders and securities, including exits (up to 20)
InvestorSecurityInstrumentReport periodFiledValueQuantityUnitsChangeSource
D.E. ShawIOVANCE BIOTHERAPEUTICS INCSHARE2026-09-302026-11-16 00:00:00135802003.00 USD9163428.000000SharesaddOriginal filing
Bridgewater AssociatesIOVANCE BIOTHERAPEUTICS INCSHARE2026-09-302026-11-16 00:00:007729312.00 USD521546.000000SharesbuyOriginal filing
Renaissance Technologies LLCIOVANCE BIOTHERAPEUTICS INCSHARE2026-09-302026-11-12 00:00:003819114.00 USD257700.000000SharesbuyOriginal filing
Gotham Asset ManagementIOVANCE BIOTHERAPEUTICS INCSHARE2026-09-302026-11-16 00:00:002192530.00 USD147944.000000SharesbuyOriginal filing

Public disclosures can be delayed, incomplete, or amended. Report period describes a position date; transaction date describes a reported transaction; filed describes submission. A recent filing or page update does not establish a current holding. A dash means unavailable or not comparable, not zero.

This public summary shows the default reporting scope. Enable JavaScript for interactive filters, charts, and additional rows.

How to read the data · Disclaimer

Read as Markdown